Published Date: September 2026 | Pages: 294
REPORT HIGHLIGHT
Biomedical Microelectromechanical Systems Market size was valued at US$ 7,060.5 Million in 2025, expanding at a CAGR of 13.1% from 2026 to 2033.
Biomedical microelectromechanical systems (BioMEMS)...
Published Date: September 2026 | Pages: 301
REPORT HIGHLIGHT
ARMET-like Protein 1 Market size was valued at US$ 84.7 Million in 2025, expanding at a CAGR of 8.1% from 2026 to 2033.
The ARMET-like Protein 1 market consists of research-grade recombinant cereb...
Published Date: September 2026 | Pages: 303
REPORT HIGHLIGHT
Acromegaly Treatment Market size was valued at US$ 1,807.6 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.
The acromegaly treatment market comprises a wide range of drug therapies...
Published Date: September 2026 | Pages: 305
REPORT HIGHLIGHT
Ewing Sarcoma Therapeutics Market size was valued at US$ 980.2 Million in 2025, expanding at a CAGR of 7.3% from 2026 to 2033.
Ewing Sarcoma Therapeutics Market refers to drugs that treat the rare...
Published Date: September 2026 | Pages: 308
REPORT HIGHLIGHT
Hereditary Angioedema Therapeutics Market size was valued at US$ 3,490.6 Million in 2025, expanding at a CAGR of 10.6% from 2026 to 2033.
The Hereditary Angioedema (HAE) Therapeutics Market compri...
Published Date: August 2026 | Pages: 289
REPORT HIGHLIGHT
Vitreoretinal Surgery Devices Market size was valued at US$ 780.1 Million in 2025, expanding at a CAGR of 4.8% from 2026 to 2033.
Vitreoretinal Surgery Devices Market consists of surgical systems,...
Published Date: August 2026 | Pages: 294
REPORT HIGHLIGHT
GMP Plasmid DNA Manufacturing Market size was valued at US$ 278.65 Million in 2025, expanding at a CAGR of 9.5% from 2026 to 2033.
GMP Plasmid DNA Manufacturing is the creation of plasmid DNA in a...
Published Date: August 2026 | Pages: 305
REPORT HIGHLIGHT
Oligonucleotide Therapeutics Market size was valued at US$ 7,180.2 Million in 2025, expanding at a CAGR of 20.3% from 2026 to 2033.
Oligonucleotide therapeutics represent a class of chemically eng...
Published Date: August 2026 | Pages: 345
REPORT HIGHLIGHT
Non-Alcoholic Fatty Liver Disease Market size was valued at US$ 3,405.2 Million in 2025, expanding at a CAGR of 16.3% from 2026 to 2033.
Non-alcoholic fatty liver disease (NAFLD) encompasses pharm...
Published Date: August 2026 | Pages: 289
REPORT HIGHLIGHT
Molecular Switch Targeting Therapies Market size was valued at US$ 830.4 Million in 2025, expanding at a CAGR of 13.5% from 2026 to 2033.
Molecular switch targeting therapies are innovative medici...
